Meanwhile, ADAM10 has been recognized to promote cell migration in multiple cancers [21] including HCC [9, 15], and so inhibition of ADAM10 has been demonstrated to have anti-migratory effects. The gene discussed is ADAM10; the disease is hepatocellular carcinoma.